SC
CORT icon

Savant Capital’s Corcept Therapeutics CORT Stock Holding History

Savant Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292K Buy
7,250
+1,200
+20% +$44.9K ﹤0.01% 1191
2025
Q4 		$211K Sell
6,050
-395
-6% -$31K ﹤0.01% 1267
2025
Q3 		$536K Buy
6,445
+420
+7% +$30.4K ﹤0.01% 771
2025
Q2 		$442K Sell
6,025
-3
-0% -$218 ﹤0.01% 788
2025
Q1 		$689K Sell
6,028
-12,361
-67% -$752K 0.01% 583
2024
Q4 		$927K Buy
18,389
+21
+0.1% +$1.1K 0.01% 681
2024
Q3 		$850K Buy
18,368
+43
+0.2% +$1.53K 0.01% 702
2024
Q2 		$595K Buy
18,325
+5,602
+44% +$153K 0.01% 732
2024
Q1 		$320K Buy
+12,723
New +$301K ﹤0.01% 880

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return